thiamine has been researched along with Autoimmune Diabetes in 36 studies
thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 8.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
| "There is a lack of information regarding thiamine status in children with diabetic ketoacidosis (DKA)." | 8.31 | Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience. ( Abdelaziz, TA; Atfy, M; Baz, EG; Elalawi, SM, 2023) |
| "Thiamine deficiency has been documented in adults with diabetes and in a single report of reversible encephalopathy in a child with diabetic ketoacidosis." | 7.81 | Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study. ( Clark, JA; Lieh-Lai, M; Rosner, EA; Strezlecki, KD, 2015) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 7.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 7.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 7.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "Thiamine deficiency has been linked to microvascular complications in patients with diabetes mellitus (DM)." | 5.38 | Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. ( Abd-Alrahman, SH; Al-Attas, OS; Al-Daghri, NM; Alfadda, AA; Sabico, S, 2012) |
| "5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)." | 4.80 | Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998) |
| "There is a lack of information regarding thiamine status in children with diabetic ketoacidosis (DKA)." | 4.31 | Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience. ( Abdelaziz, TA; Atfy, M; Baz, EG; Elalawi, SM, 2023) |
| "Thiamine-responsive megaloblastic anemia (TRMA) syndrome is a rare disease comprising a classic triad of megaloblastic anemia, diabetes mellitus, and early-onset sensorineural deafness." | 3.91 | An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome. ( Kutlucan, A, 2019) |
| "Thiamine-responsive megaloblastic anemia (TRMA) is a rare autosomal recessive inherited disease characterized by the clinical triad of megaloblastic anemia, sensorineural deafness, and diabetes mellitus." | 3.91 | TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report. ( Cheng, Q; Ding, Y; Li, Q; Li, X; Wang, J; Wang, X; Yao, R, 2019) |
| "Thiamine deficiency has been documented in adults with diabetes and in a single report of reversible encephalopathy in a child with diabetic ketoacidosis." | 3.81 | Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study. ( Clark, JA; Lieh-Lai, M; Rosner, EA; Strezlecki, KD, 2015) |
| "Thiamine responsive megaloblastic anemia syndrome (TRMA) is a clinical triad characterized by thiamine-responsive anemia, diabetes mellitus and sensorineural deafness." | 3.75 | Thiamine responsive megaloblastic anemia syndrome. ( Ezhilarasi, S; Ganesh, R; Gowrishankar, K; Rajajee, S; Vasanthi, T, 2009) |
| "Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred." | 3.71 | A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001) |
| "The triad of thiamine-responsive anaemia, diabetes mellitus and deafness has been reported in 15 patients with macrocytic anaemia, sometimes associated with moderate thrombocytopenia." | 3.70 | Thiamine-responsive myelodysplasia. ( Ayas, M; Bazarbachi, A; Haidar, JH; Muakkit, S; Salem, Z; Solh, H; Taher, A, 1998) |
| "Thiamine-responsive megaloblastic anemia, also known as "TRMA" or "Rogers syndrome," is an early-onset autosomal recessive disorder defined by the occurrence of megaloblastic anemia, diabetes mellitus, and sensorineural deafness, responding in varying degrees to thiamine treatment." | 3.69 | Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. ( Barrett, T; Buist, N; Cohen, N; Fauré, S; Mandel, H; Neufeld, EJ; Raz, T; Stagg, A; Szargel, R; Yandava, CN, 1997) |
| "We have investigated thiamine metabolism and transport in the erythrocytes of two patients from unrelated families with thiamine responsive megaloblastic anaemia associated with diabetes mellitus and sensorineural deafness." | 3.67 | Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia. ( Andria, G; De Vizia, B; Longo, G; Patrini, C; Poggi, V; Rindi, G, 1989) |
| "Erythrocyte transketolase activity (ETKA) and the effect of adding thiamine pyrophosphate have been measured in a group of 27 healthy individuals and in 37 patients diagnosed as having diabetes mellitus, anemia, polyneuritis, or malnourishment secondary to vascular disease of the brain." | 3.65 | The transketolase assay of thiamine in some diseases. ( Kjosen, B; Seim, SH, 1977) |
| "Male participants with and without type 1 diabetes were studied in the General Clinical Research Centre of the Albert Einstein College of Medicine." | 2.73 | Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. ( Brownlee, M; Du, X; Edelstein, D, 2008) |
| "165 patients with symmetrical, distal diabetic polyneuropathy were randomised to one of three treatment groups entering the wash-out phase and 133/124 patients were analysed in the ITT/PP analysis: Benfotiamine 600 mg per day (n=47/43), benfotiamine 300 mg per day (n=45/42) or placebo (n=41/39)." | 2.73 | Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. ( Achenbach, U; Bretzel, RG; Federlin, K; Gaus, W; Stracke, H, 2008) |
| "Thiamine plays an important role in the regulation of glucose metabolism and pancreatic beta-cell functioning." | 2.69 | Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus. ( Franzese, A; Laforenza, U; Patrini, C; Poggi, V; Tenore, A; Valerio, G, 1999) |
| "Thiamine and phosphate were thus replaced." | 1.56 | [Increasing lactate levels during treatment of diabetic ketoacidosis]. ( Feldhaus, F; Lange-Brock, N, 2020) |
| "Thiamine (vitamin B1) is an essential enzyme cofactor in most organisms required at several stages of anabolic and catabolic intermediary metabolism." | 1.42 | Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1). ( Abd-Alrahman, SH; Al-Daghri, NM; Alharbi, M; Alokail, MS; Sheshah, E; Wani, K, 2015) |
| "Thiamine deficiency has been linked to microvascular complications in patients with diabetes mellitus (DM)." | 1.38 | Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria. ( Abd-Alrahman, SH; Al-Attas, OS; Al-Daghri, NM; Alfadda, AA; Sabico, S, 2012) |
| "Thiamine (75 mg/day) was commenced at a single oral dose with a rapid increase of Hb level after a few days of therapy." | 1.29 | [Wolfram syndrome. Personal experience]. ( Bizzarri, C; Conti, G; Falsini, B; Marietti, G; Perrone, F; Ricci, B; Zampino, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (13.89) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 9 (25.00) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelaziz, TA | 3 |
| Atfy, M | 3 |
| Elalawi, SM | 3 |
| Baz, EG | 3 |
| Chehayeb, RJ | 1 |
| Ilagan-Ying, YC | 1 |
| Sankey, C | 1 |
| Feldhaus, F | 1 |
| Lange-Brock, N | 1 |
| Kutlucan, A | 1 |
| Li, X | 1 |
| Cheng, Q | 1 |
| Ding, Y | 1 |
| Li, Q | 1 |
| Yao, R | 1 |
| Wang, J | 1 |
| Wang, X | 1 |
| Rosner, EA | 1 |
| Strezlecki, KD | 1 |
| Clark, JA | 1 |
| Lieh-Lai, M | 1 |
| Al-Daghri, NM | 2 |
| Alharbi, M | 1 |
| Wani, K | 1 |
| Abd-Alrahman, SH | 2 |
| Sheshah, E | 1 |
| Alokail, MS | 1 |
| Du, X | 1 |
| Edelstein, D | 1 |
| Brownlee, M | 1 |
| Vindedzis, SA | 1 |
| Stanton, KG | 1 |
| Sherriff, JL | 1 |
| Dhaliwal, SS | 1 |
| Ganesh, R | 1 |
| Ezhilarasi, S | 1 |
| Vasanthi, T | 1 |
| Gowrishankar, K | 1 |
| Rajajee, S | 1 |
| Al-Attas, OS | 1 |
| Alfadda, AA | 1 |
| Sabico, S | 1 |
| Fraser, DA | 1 |
| Diep, LM | 1 |
| Hovden, IA | 1 |
| Nilsen, KB | 1 |
| Sveen, KA | 1 |
| Seljeflot, I | 1 |
| Hanssen, KF | 1 |
| Katare, R | 1 |
| Oikawa, A | 1 |
| Cesselli, D | 1 |
| Beltrami, AP | 1 |
| Avolio, E | 1 |
| Muthukrishnan, D | 1 |
| Munasinghe, PE | 1 |
| Angelini, G | 1 |
| Emanueli, C | 1 |
| Madeddu, P | 1 |
| Ziegler, D | 1 |
| Tesfaye, S | 1 |
| Kempler, P | 1 |
| Engelen, L | 1 |
| Stehouwer, CD | 1 |
| Schalkwijk, CG | 1 |
| Lerner, EB | 1 |
| Billittier, AJ | 1 |
| Lance, DR | 1 |
| Janicke, DM | 1 |
| Teuscher, JA | 1 |
| BRODERZON, EA | 1 |
| LUKASHIK, NK | 1 |
| KOLTUNOVA, VI | 1 |
| HAUGEN, HN | 1 |
| Haupt, E | 1 |
| Ledermann, H | 1 |
| Köpcke, W | 1 |
| Davidson, A | 1 |
| Hartley, PS | 1 |
| Berman, P | 1 |
| Shuttleworth, MH | 1 |
| Jermendy, G | 1 |
| Alzahrani, AS | 1 |
| Baitei, E | 1 |
| Zou, M | 1 |
| Shi, Y | 1 |
| Thornalley, PJ | 1 |
| Babaei-Jadidi, R | 1 |
| Al Ali, H | 1 |
| Rabbani, N | 1 |
| Antonysunil, A | 1 |
| Larkin, J | 1 |
| Ahmed, A | 1 |
| Rayman, G | 1 |
| Bodmer, CW | 1 |
| Stracke, H | 1 |
| Gaus, W | 1 |
| Achenbach, U | 1 |
| Federlin, K | 1 |
| Bretzel, RG | 1 |
| Marietti, G | 1 |
| Bizzarri, C | 1 |
| Perrone, F | 1 |
| Zampino, G | 1 |
| Conti, G | 1 |
| Falsini, B | 1 |
| Ricci, B | 1 |
| Akinci, A | 1 |
| Teziç, T | 1 |
| Ertürk, G | 1 |
| Tarim, O | 1 |
| Dalva, K | 1 |
| Neufeld, EJ | 2 |
| Mandel, H | 1 |
| Raz, T | 1 |
| Szargel, R | 1 |
| Yandava, CN | 1 |
| Stagg, A | 1 |
| Fauré, S | 1 |
| Barrett, T | 1 |
| Buist, N | 1 |
| Cohen, N | 1 |
| Valerio, G | 2 |
| Franzese, A | 2 |
| Poggi, V | 4 |
| Tenore, A | 2 |
| Bazarbachi, A | 1 |
| Muakkit, S | 1 |
| Ayas, M | 1 |
| Taher, A | 1 |
| Salem, Z | 1 |
| Solh, H | 1 |
| Haidar, JH | 1 |
| Patrini, C | 2 |
| Laforenza, U | 1 |
| Villa, V | 1 |
| Rivellese, A | 1 |
| Di Salle, F | 1 |
| Iovine, C | 1 |
| Capaldo, B | 1 |
| Gritli, S | 1 |
| Omar, S | 1 |
| Tartaglini, E | 1 |
| Guannouni, S | 1 |
| Fleming, JC | 1 |
| Steinkamp, MP | 1 |
| Berul, CI | 1 |
| Hafsia, R | 1 |
| Jilani, SB | 1 |
| Belhani, A | 1 |
| Hamdi, M | 1 |
| Viana, MB | 1 |
| Carvalho, RI | 1 |
| Kjosen, B | 1 |
| Seim, SH | 1 |
| Rindi, G | 1 |
| De Vizia, B | 1 |
| Longo, G | 1 |
| Andria, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pirofosfato de Tiamina Como Coadyuvante de la Metformina en el Tratamiento de Pacientes Con Diabetes Mellitus Tipo 2[NCT04053621] | 92 participants (Anticipated) | Interventional | 2021-01-31 | Not yet recruiting | |||
| The Role of the Glucosamine Pathway and Reactive Oxygen Species in the Pathogenesis of Diabetic Complications[NCT00703989] | 21 participants (Actual) | Interventional | 2005-02-28 | Completed | |||
| Can Oral Benfotiamine Supplementation Influence Progression of Microvascular Complications in Patients With Type 1 Diabetes?[NCT00117026] | Phase 1/Phase 2 | 67 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| A Double-Blind Clinical Trial of Benfotiamine Treatment in Diabetic Nephropathy[NCT00565318] | Phase 4 | 86 participants (Anticipated) | Interventional | 2007-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for thiamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Current therapeutic interventions in the glycation pathway: evidence from clinical studies.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2013 |
Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.
Topics: Adolescent; Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Deafness; Diabetes Mellitus, Typ | 1998 |
6 trials available for thiamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Cytochrome P-450 Enzyme System; Diabe | 2008 |
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Biomarkers; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Administration S | 2012 |
Can paramedics safely treat and discharge hypoglycemic patients in the field?
Topics: Brain Diseases; Consent Forms; Diabetes Mellitus, Type 1; Emergency Medical Services; Emergency Medi | 2003 |
Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type | 2005 |
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
Topics: Adjuvants, Immunologic; Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic | 2008 |
Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus.
Topics: Adolescent; Age of Onset; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blin | 1999 |
28 other studies available for thiamine and Autoimmune Diabetes
| Article | Year |
|---|---|
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Thiamine status during treatment of diabetic ketoacidosis in children - tertiary care centre experience.
Topics: Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Male; Retrospective Studies | 2023 |
Addressing Cognitive Biases in Interpreting an Elevated Lactate in a Patient with Type 1 Diabetes and Thiamine Deficiency.
Topics: Beriberi; Bias; Cognition; COVID-19; Diabetes Mellitus, Type 1; Female; Humans; Lactic Acid; Pandemi | 2023 |
[Increasing lactate levels during treatment of diabetic ketoacidosis].
Topics: Blood Gas Analysis; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Humans; Insulin; Thiam | 2020 |
An Adult Case of Thiamine-Sensitive Megaloblastic Anemia Syndrome Accidentally Diagnosed Myelodysplastic Syndrome.
Topics: Adult; Anemia, Megaloblastic; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diagnosis | 2019 |
TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Topics: Adult; Anemia, Megaloblastic; Arrhythmias, Cardiac; Atrophy; Brain; Cerebral Infarction; Child; Diab | 2019 |
Low thiamine levels in children with type 1 diabetes and diabetic ketoacidosis: a pilot study.
Topics: Adolescent; Biomarkers; Child; Child, Preschool; Critical Care; Diabetes Mellitus, Type 1; Diabetic | 2015 |
Biochemical changes correlated with blood thiamine and its phosphate esters levels in patients with diabetes type 1 (DMT1).
Topics: Adult; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 1; Esters; Female; Humans; Male; Metaboli | 2015 |
Thiamine deficiency in diabetes - is diet relevant?
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet; Dietary Supplements; Female | 2008 |
Thiamine responsive megaloblastic anemia syndrome.
Topics: Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Diabetes Mellitus, Type 1; Female; Follow-Up | 2009 |
Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Blood Glucose; Child; Child, Preschool; Cholesterol; Chromatog | 2012 |
Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes.
Topics: Animals; Antigens, CD; Antigens, Ly; Apoptosis; Biomarkers; Blood Glucose; Cell Proliferation; Cell | 2013 |
Comment on: Fraser et al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care 2012
Topics: Biomarkers; Diabetes Mellitus, Type 1; Female; Humans; Male; Peripheral Nerves; Thiamine | 2012 |
[EFFECT OF THIAMINE DIPHOSPHATE ON LIPID METABOLISM IN PATIENTS WITH DIABETES MELLITUS].
Topics: Adolescent; Child; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Insulin; Lecit | 1963 |
THE BLOOD CONCENTRATION OF THIAMINE IN DIABETES.
Topics: Blood; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 1; Drug Therapy; Fasting; Geriatric | 1964 |
[Oral benfotiamine therapy. Thus you protect the nerves of diabetic patients].
Topics: Administration, Oral; Controlled Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Melli | 2004 |
Megaloblastic anaemia, diabetes and deafness in a 2-year-old child.
Topics: Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Female; Humans; Thiami | 2005 |
Evaluating thiamine deficiency in patients with diabetes.
Topics: Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Mi | 2006 |
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Topics: Adolescent; Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; H | 2006 |
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.
Topics: Albuminuria; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies | 2007 |
[Wolfram syndrome. Personal experience].
Topics: Autoantibodies; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Hu | 1995 |
Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness.
Topics: Anemia, Megaloblastic; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hearing Loss, Sensorine | 1993 |
Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping.
Topics: Alaska; Anemia, Megaloblastic; Arabs; Chromosome Mapping; Chromosomes, Human, Pair 1; Consanguinity; | 1997 |
Thiamine-responsive myelodysplasia.
Topics: Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorineural; Humans; Mal | 1998 |
Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome.
Topics: Adult; Anemia, Megaloblastic; Angiography; Diabetes Mellitus, Type 1; Female; Hearing Loss, Sensorin | 2000 |
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
Topics: Anemia, Megaloblastic; Bone Marrow Cells; Cardiomyopathy, Dilated; Carrier Proteins; Child, Preschoo | 2001 |
Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome?
Topics: Adult; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Diabetes Melli | 1978 |
The transketolase assay of thiamine in some diseases.
Topics: Anemia, Macrocytic; Anemia, Pernicious; Apoenzymes; Diabetes Mellitus; Diabetes Mellitus, Type 1; Er | 1977 |
Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia.
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Er | 1989 |